ACRS Dividend History & Analysis | Yield
ACRS has a dividend yield of and paid per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Pharmaceuticals
| SYMBOL | MARKET CAP USD | YIELD TTM | YIELD ON COST 5y |
|---|---|---|---|
| SAN PA Sanofi |
104,257 M | 5.54% | 5.85% |
| BMY NYSE Bristol-Myers Squibb |
132,204 M | 4.71% | 4.60% |
| GSK NYSE GlaxoSmithKline |
104,486 M | 3.72% | 5.34% |
| TAK NYSE Takeda Pharmaceutical |
55,727 M | 3.92% | 4.69% |
| NVS NYSE Novartis |
297,139 M | 3.06% | 6.20% |
| MRK NYSE Merck |
316,953 M | 3.29% | 5.16% |
| VTRS NASDAQ Viatris |
18,971 M | 3.88% | 3.96% |
| NOVN SW Novartis |
296,106 M | 2.99% | 5.50% |
| ORNBV HE Orion |
13,266 M | 2.56% | 5.77% |
| HLUN-B CO H Lundbeck |
6,378 M | 3.08% | 3.26% |
| SYMBOL | MARKET CAP USD | GROWTH RATE | CONSISTENCY |
|---|---|---|---|
| HLUN-B CO H Lundbeck |
6,378 M | 26.64% | 100.0% |
| LLY NYSE Eli Lilly |
1,062,444 M | 15.22% | 100.0% |
| NVS NYSE Novartis |
297,139 M | 8.79% | 100.0% |
| MRK NYSE Merck |
316,953 M | 5.41% | 100.0% |
| RPRX NASDAQ Royalty Pharma |
32,972 M | 5.47% | 100.0% |
| SAN PA Sanofi |
104,257 M | 5.39% | 100.0% |
| JNJ NYSE Johnson & Johnson |
619,296 M | 4.89% | 100.0% |
| IPN PA Ipsen |
15,433 M | 7.55% | 98.0% |
| NOVN SW Novartis |
296,106 M | 4.53% | 100.0% |
| BMY NYSE Bristol-Myers Squibb |
132,204 M | 4.43% | 100.0% |
ACRS Dividend History
Dividend Monthly Return EX date, 0 years of data
Average monthly dividend return by ex-dividend date. The score below shows reliability based on how consistently dividends were paid in that month.
ACRS Dividend FAQ
As of August 2026, ACRS's dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 5.90.
As of August 2026 ACRS does not pay a dividend.
Over the last 12 months, ACRS has issued dividend payments.
Based on historical data, the forecasted dividends per share for ACRS for the next payments are between 0 (+0.0%) and 0 (+0.0%). This suggests the dividend will remain relatively stable. The expected Yield for the next 12 months is about -%.
The next Ex-Dividend date for Aclaris Therapeutics (ACRS) is currently unknown.
The next Ex-Dividend date for Aclaris Therapeutics (ACRS) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.
ACRS's average dividend growth rate over the past 5 years is -% per year.
ACRS's 5-Year Yield on Cost is -%. If you bought ACRS's shares at 15.11 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.
ACRS Payout Consistency is 0.0%. The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
ACRS's % Dividend Yield is considered as unknown.
The Dividend Payout Ratio of ACRS is unknown.
ACRS's Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.
ACRS Outstanding Shares Analysis
Key Metric Definitions
Annual dividend per share divided by current share price.
Percentage of earnings paid as dividends. Below 60% = safe, above 100% = unsustainable.
Percentage of Free Cash Flow paid as dividends. More reliable than Payout Ratio since it measures actual cash.
Compound annual growth rate of dividends over the last 5 years.
Reliability of dividend payments over lifetime. Penalizes cuts and pauses.
Your effective yield if you bought 5 years ago. Shows dividend growth impact over time.
Consecutive years of dividend payments. 25+ years = Dividend Aristocrat.
Proprietary score (0-100) combining yield, growth, safety and consistency.
Last update: 2026-08-10 02:05 UTC